Clinical Trials Browser

Completed × enasidenib × 90 days × Clear all

NCT05282459 2026-04-17

Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation

Phase 1/2 Completed

17 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid

NCT05102370 2026-01-27

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Phase 1 Completed

Classical hematology

Clonal Cytopenia of Undetermined Significance